Financhill
Buy
68

NBIX Quote, Financials, Valuation and Earnings

Last price:
$139.38
Seasonality move :
9.43%
Day range:
$135.94 - $139.10
52-week range:
$110.95 - $157.98
Dividend yield:
0%
P/E ratio:
37.27x
P/S ratio:
6.42x
P/B ratio:
5.18x
Volume:
920.8K
Avg. volume:
1M
1-year change:
5.98%
Market cap:
$14.1B
Revenue:
$1.9B
EPS (TTM):
$3.73

Earnings Data

Next earnings date for NBIX
Feb 07
2025
Most recent earnings per share
$1.24
Missed by $0.58
(Oct 30/2024)
Consensus Estimate
$1.82
(Oct 30/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NBIX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/07/2025 Q4 $630M -- -- $1.87 --
10/30/2024 Q3 $602.8M $622.1M $1.24 $1.82 -$0.58
08/01/2024 Q2 $546.6M $590.2M $0.63 $1.53 -$0.90
05/01/2024 Q1 $512M $515.3M $0.42 $1.29 -$0.87
02/07/2024 Q4 $518.4M $515.2M $1.44 $1.51 -$0.07
10/31/2023 Q3 -- -- $0.82 $1.33 -$0.51
08/01/2023 Q2 -- -- $0.95 $1.12 -$0.17
05/03/2023 Q1 -- -- -$0.79 $0.74 -$1.53
02/06/2023 Q4 -- -- $0.88 $1.44 -$0.56
11/01/2022 Q3 -- -- $0.69 $1.12 -$0.43
08/04/2022 Q2 -- -- -$0.18 $0.89 -$1.07
05/04/2022 Q1 -- -- $0.14 $0.59 -$0.45
02/11/2022 Q4 -- -- -$0.08 $0.88 -$0.96
11/01/2021 Q3 -- -- $0.23 $0.80 -$0.57
08/03/2021 Q2 -- -- $0.43 $0.76 -$0.33
05/05/2021 Q1 -- -- $0.33 $0.72 -$0.39
02/04/2021 Q4 -- -- $3.58 $0.90 $2.68
11/09/2020 Q3 -- -- -$0.62 $1.25 -$1.87
08/03/2020 Q2 -- -- $0.81 $1.02 -$0.21
05/06/2020 Q1 -- -- $0.39 $0.64 -$0.25
02/04/2020 Q4 -- -- $0.35 $0.75 -$0.40
11/04/2019 Q3 -- -- $0.56 $0.64 -$0.08
07/29/2019 Q2 -- -- $0.54 $0.25 $0.29
04/29/2019 Q1 -- -- -$1.12 -$0.89 -$0.23
02/05/2019 Q4 -- -- $0.19 $0.19 -$0.00
11/05/2018 Q3 -- -- $0.52 $0.49 $0.03
07/31/2018 Q2 -- -- -$0.07 -$0.18 $0.11
04/30/2018 Q1 -- -- -$0.47 -$0.30 -$0.17
02/13/2018 Q4 -- -- $0.07 $0.16 -$0.09
11/01/2017 Q3 -- -- -$0.13 -$0.53 $0.40
08/03/2017 Q2 -- -- -$0.68 -$0.65 -$0.03
05/09/2017 Q1 -- -- -$0.90 -$0.72 -$0.18
02/14/2017 Q4 -- -- -- -- --
11/02/2016 Q3 -- -- -- -- --
08/03/2016 Q2 -- -- -- -- --
05/05/2016 Q1 -- -- -- -- --
02/11/2016 Q4 -- -- -- -- --
10/29/2015 Q3 -- -- -- -- --
07/29/2015 Q2 -- -- -- -- --
04/30/2015 Q1 -- -- -- -- --
02/09/2015 Q4 -- -- -- -- --

Neurocrine Biosciences Earnings Questions

  • How Much did Neurocrine Biosciences Generate in Revenue Last Quarter?

    Neurocrine Biosciences reported $622.1M worth of top line sales in its most recent quarter.

  • Did Neurocrine Biosciences Beat Earnings Last Quarter?

    Neurocrine Biosciences announced earnings per share of $1.24 which represents a miss of analyst forecast a $1.82 per share.

  • Is Neurocrine Biosciences Profitable?

    Neurocrine Biosciences reported $614.1M that represents $5.89 per share over the last quarter.

  • What is the Analyst Consensus for Neurocrine Biosciences EPS Next Year?

    Neurocrine Biosciences's earnings are forecast to grow from $2.47 per share to $4.10 per share next year representing an increase of 162.71%.

  • When is Neurocrine Biosciences's Earnings Date?

    Neurocrine Biosciences's next earnings date is February 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is down 3.22% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 4.72% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is down 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock